Preclinical safety assessment of GP-EGF lyophilized powder | |
He, Jinlian[1]; Zhang, Youying[2]; Li, Jianan[1]; Tang, Jianzhong[1]; Zhang, Xiaona[1]; Zheng, Quan[3]; Chen, Yurong[4]; Huang, Yadong[1,2]; Xiang, Qi[1,2] | |
2017 | |
卷号 | 11期号:3页码:227 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4736507 |
专题 | 暨南大学 |
作者单位 | 1.[1] Institute of Biomedicine, Guangdong Provincial Key Laboratory of Bioengineering Medicine, Jinan University, Guangzhou, 510632, China 2.[2] College of Pharmacy, Jinan University, Guangzhou, 510632, China 3.[3] Queen Plastic Surgery Hospital, Chongqing, 401120, China 4.[4] Guangzhou Yuanxiang Biological Technology Co., Ltd., Guangzhou, 510632, China |
推荐引用方式 GB/T 7714 | He, Jinlian[1],Zhang, Youying[2],Li, Jianan[1],et al. Preclinical safety assessment of GP-EGF lyophilized powder[J],2017,11(3):227. |
APA | He, Jinlian[1].,Zhang, Youying[2].,Li, Jianan[1].,Tang, Jianzhong[1].,Zhang, Xiaona[1].,...&Xiang, Qi[1,2].(2017).Preclinical safety assessment of GP-EGF lyophilized powder.,11(3),227. |
MLA | He, Jinlian[1],et al."Preclinical safety assessment of GP-EGF lyophilized powder".11.3(2017):227. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论